OPKO Health (NASDAQ: OPK) reported Q2 EPS of ($0.01), $0.09 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $182.2 million versus the consensus estimate of $184.7 million.

For earnings history and earnings-related data on OPKO Health (OPK) click here.